2014 Jul;14(7):1019-31. doi: 10.1517/14712598.2014.912273.Liver Int. Chronic hepatitis B virus (HBV) infection leads to a risk of developing cirrhosis and hepatocellular carcinoma. This site needs JavaScript to work properly. World J Gastroenterol. It is known that immunotherapy and cancer chemotherapy may cause hepatitis B virus (HBV) reactivation in hepatitis B surface antigen carriers and inactive chronic hepatitis B patients. The incidence of hepatitis B in the group 1, 2, and 3 was: 57.9%, 23.6%, and 0.76%, respectively, and the incidence of hepatitis C: 44.7%, 36.4%, and 5.9%, respectively. Clipboard, Search History, and several other advanced features are temporarily unavailable. 2011 Jul;52(7):804, 806-8, 810-4. doi: 10.1007/s00108-010-2793-0.Mehrabi A, Esmaeilzadeh M, Fonouni H, Hafezi M, Rahbari NN, Golriz M, Majlesara A, Rad MT, Sadeghi M, Schmidt J, Ganten TM.Langenbecks Arch Surg. Clipboard, Search History, and several other advanced features are temporarily unavailable. Post-Exposure Prophylaxis after Non-Occupational Exposure to HIV. We read from the article written by Liu et al that Lamivudine was given inadequate time for antiviral prophylaxis. Post exposure prophylaxis guidance for hepatitis B are adapted from the PHLS Hepatitis Sub-Committee guidance on post exposure prophylaxis. Baishideng Publishing Group Inc. 2007 Aug;132(34-35):1775-82. doi: 10.1055/s-2007-984967.Semin Liver Dis. This site needs JavaScript to work properly. Free PMC article 2012 Jun;397(5):697-710. doi: 10.1007/s00423-011-0795-6. 2007 Dec;45(12):1281-328. doi: 10.1055/s-2007-963714.Wedemeyer H, Cornberg M, Protzer U, Berg T, Dollinger MM.Dtsch Med Wochenschr. Mehrabi A, Esmaeilzadeh M, Fonouni H, Hafezi M, Rahbari NN, Golriz M, Majlesara A, Rad MT, Sadeghi M, Schmidt J, Ganten TM. COVID-19 is an emerging, rapidly evolving situation. 2015 Sep 21;21(35):10251-2. doi: 10.3748/wjg.v21.i35.10251. 2011 Jan;31 Suppl 1:104-10. doi: 10.1111/j.1478-3231.2010.02396.x.World J Hepatol. Unable to load your delegates due to an error Hepatitis B reactivation and timing for prophylaxis. Mehrabi A, et al. 2011 Mar;52(3):250-64. doi: 10.1007/s00108-010-2678-2.Z Rheumatol. Georg Thieme Verlag Stuttgart, New York 2014 May 7;20(17):5165-70. doi: 10.3748/wjg.v20.i17.5165.Huang YH, Hsiao LT, Hong YC, Chiou TJ, Yu YB, Gau JP, Liu CY, Yang MH, Tzeng CH, Lee PC, Lin HC, Lee SD.J Clin Oncol. 2013 Aug 1;31(22):2765-72. doi: 10.1200/JCO.2012.48.5938. Hepatitis B vaccine is given as a series of 2, 3, or 4 shots, depending on the vaccine formula and health needs of the person getting vaccinated. Derived from the VHA Corporate Data Warehouse, the 2014 data is from an earlier analysis (5) while the 2015‐2016 data were analyzed within this study. The percent of the failure of active prophylaxis in the subgroup a, b, and c was: 29%, 53%, and 93%, respectively. Name must be less than 100 characters Epub 2011 May 2.Internist (Berl). Unable to load your delegates due to an error Unable to load your collection due to an error COVID-19 is an emerging, rapidly evolving situation. Please enable it to take advantage of the complete set of features! In Australia, the risk of hepatitis B virus (HBV) transmission from single sexual contact is low. 2016 Mar 18;8(8):385-94. doi: 10.4254/wjh.v8.i8.385.World J Gastroenterol. Please enable it to take advantage of the complete set of features! 2005 Dec;118(12):1413. doi: 10.1016/j.amjmed.2005.06.021.Curr Infect Dis Rep. 2013 Feb;15(1):31-8. doi: 10.1007/s11908-012-0307-z.Internist (Berl). Georg Thieme Verlag Stuttgart, New York Free PMC article Unable to load your collection due to an error Increases in VHA national hepatitis B testing and antiviral prophylaxis rates with initiation of anti‐CD20 antibody treatment are profiled in the chevron figure over time (2014‐2017). Hepatitis B All individuals presenting for PEP are assessed for the possibility of hepatitis B exposure. 2014 May 7;20(17):5165-70. doi: 10.3748/wjg.v20.i17.5165.World J Gastroenterol. It is known that immunotherapy and cancer chemotherapy may cause hepatitis B virus (HBV) … Additionally the incidence of hepatitis C was assessed to evaluate the role of unspecific prophylaxis. 2014 May 7;20(17):5165-70.